Table 3 Baseline comparison of blood routine and tumor biomarkers in different responses to nCRT from the internal discovery cohort
Laboratory index | TR | PR | p |
|---|---|---|---|
Haemoglobin (g/L) | 130.29 ± 17.67 | 133.30 ± 13.43 | 0.694 |
RBC (1012/L) | 4.46 ± 0.46 | 4.52 ± 0.46 | 0.790 |
WBC (109/L) | 5.80 ± 2.08 | 5.91 ± 2.00 | 0.907 |
Neutrophil | 0.63 ± 0.07 | 0.62 ± 0.10 | 0.963 |
Lymphocyte | 0.30 ± 0.07 | 0.28 ± 0.07 | 0.492 |
Monocyte | 0.06 ± 0.014 | 0.06 ± 0.018 | 0.669 |
Eosinophil | 0.01 ± 0.005 | 0.02 ± 0.017 | 0.169 |
Basophil | 0.003 ± 0.002 | 0.004 ± 0.003 | 0.421 |
Platelet (109/L) | 252 ± 58 | 200 ± 98 | 0.231 |
NLR | 2.22 ± 0.77 | 2.48 ± 1.02 | 0.587 |
Fibrinogen (g/L) | 3.38 ± 0.74 | 3.47 ± 0.47 | 0.764 |
CEA (μg/L) | 5.50 ± 4.45 | 8.08 ± 8.61 | 0.519 |
AFP (μg/L) | 3.17 ± 2.45 | 4.51 ± 3.55 | 0.445 |
CA125 (U/mL) | 19.44 ± 13.49 | 11.46 ± 3.94 | 0.194 |
CA19-9 (U/mL) | 43.35 ± 48.64 | 17.15 ± 19.78 | 0.184 |